Medical Director, Randox Health

Dr Gary Smyth is the Medical Director of Randox Health. He works closely with many areas of the business, providing medical input into the development of new tests and services, whilst also managing the medical team. During the COVID-19 pandemic, he also became the Laboratory Director for Randox Clinical Laboratory Services. In addition to this, he works as a General Practitioner within the NHS and Private sectors.

He has an interest in preventative, integrative, and complementary medicine and the importance of whole person approaches to healthcare. His significant medical experience to date has provided him with a unique perspective on healthcare and he frequently contributes to health discussions within the media. He is a Member of the Royal College of General Practitioners and is a Fellow of the Royal Society of Medicine, the Faculty of Homeopathy, and the Royal Society for Public Health.

health scientist, RANDOX

I have worked for Randox Laboratories for over 12 years. In that time, I have worked extensively researching biomarkers of disease and producing scientific materials to aid understanding of new and existing tests.

I manage a team focused on researching new tests to identify their suitability for use as diagnostic biomarkers, with a particular focus on gastrointestinal health. Prior to joining Randox I studied at the University of Glasgow where I obtained a BSc (Hons) in Molecular and Cellular Biology and a PhD in Cardiovascular and Medical Sciences.

FOUNDER, RANDOX

Dr FitzGerald founded Randox in 1982 in a converted ‘Hen House’ at the back of his parent’s house in Crumlin, Co. Antrim.  Since then, the company has grown to over 3,000 staff worldwide including 800 R&D Scientists & Engineers, with customers in over 145 countries. Randox develop, manufacture and market a wide range of clinical and veterinary diagnostic reagents and systems. Randox supplies 100,000 laboratories globally and is the fourth largest manufacturer of clinical chemistry reagents in the world.

Dr FitzGerald was awarded the Commander of the Order of the British Empire (CBE) in 2011 for services to business in Northern Ireland. He has gained many other accolades in his career to date; named a Fellow of the Royal Academy of Engineering (FREng) and Innovation Founder of the Year 2013 from the Northern Ireland Science Park, to name a few.

Head of Genomics Strategy, RANDOX

James studied Biotechnology at the University of Nottingham where he conducted research into epigenetic regulation of the commonly referred ‘hunger suppressing hormone’, leptin. James began working for Randox as a Research and Development Scientist in 2018 where he worked on developing novel biochemical assays for detecting illness/disease. During the pandemic he managed one of the largest COVID-19 testing and sequencing labs in Europe and remains employed by Randox as Head of Genomics Strategy with interests in further understanding the human microbiome and how this affects your body.